18.737 articles found

Premotor Gray Matter Volume is Associated with Clinical Findings in Idiopathic and Genetically Determined Parkinson's Disease.

Reetz K, Siebner HR, Gaser C, Hagenah J, Buechel C, Kasten M, Petersen D, Pramstaller PP, Klein C, Binkofksi F.

Open Neuroimag J · 2008-09-27

DOI: 10.2174/1874440000802010102PMID: 19526072

METHOD OF TREATING PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS

NICOLELIS MIGUEL A L, FUENTES ROMULO A.

· 2008-09-26

Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.

Grealish S, Xie L, Kelly M, Dowd E.

Brain Res Bull · 2008-09-24

DOI: 10.1016/j.brainresbull.2008.08.018PMID: 18817852

Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.

Hoeppner J, Prudente-Morrissey L, Herpertz SC, Benecke R, Walter U.

Eur Arch Psychiatry Clin Neurosci · 2008-09-19

DOI: 10.1007/s00406-008-0840-9PMID: 18806917

Does laterality of motor impairment tell us something about cognition in Parkinson disease?

Cooper CA, Mikos AE, Wood MF, Kirsch-Darrow L, Jacobson CE, Okun MS, Rodriguez RL, Bowers D, Fernandez HH.

Parkinsonism Relat Disord · 2008-09-14

DOI: 10.1016/j.parkreldis.2008.07.009PMID: 18793864

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Dupre KB, Eskow KL, Barnum CJ, Bishop C.

Neuropharmacology · 2008-09-10

DOI: 10.1016/j.neuropharm.2008.08.031PMID: 18824001

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN.

Neuroscience · 2008-09-09

DOI: 10.1016/j.neuroscience.2008.08.035PMID: 18817851

Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease.

Fraix V, Pollak P, Vercueil L, Benabid AL, Mauguière F.

Clin Neurophysiol · 2008-09-09

DOI: 10.1016/j.clinph.2008.07.217PMID: 18783985

Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease.

Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y.

Behav Brain Res · 2008-09-04

DOI: 10.1016/j.bbr.2008.08.041PMID: 18817814

Movement disorders in multiple sclerosis: Causal or coincidental association?

Nociti V, Bentivoglio AR, Frisullo G, Fasano A, Soleti F, Iorio R, Loria G, Patanella AK, Marti A, Tartaglione T, Tonali PA, Batocchi AP.

Mult Scler · 2008-09-03

DOI: 10.1177/1352458508094883PMID: 18768580

Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors.

Al Hadithy AF, Wilffert B, Stewart RE, Looman NM, Bruggeman R, Brouwers JR, Matroos GE, van Os J, Hoek HW, van Harten PN.

Am J Med Genet B Neuropsychiatr Genet · 2008-09-01

DOI: 10.1002/ajmg.b.30746PMID: 18389501

Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.

Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL.

Mov Disord · 2008-09-01

DOI: 10.1002/mds.22190PMID: 18649391